University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 16 of 35
Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer
NCT03232892
Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser
NCT02357979
Resolving Psychological Stress
NCT03996876
Myocardial Injury and Intraoperative Tissue Oximetry in Patients Undergoing Spine Surgery
NCT03518372
Cognitive, Emotional, and Neural Responses to Acute Inflammation
NCT03294564
Implementing Pathways to Improve Pediatric Asthma Care
NCT03736603
Peripheral Nerve Blocks for Major Lower Extremity Amputations
NCT03174782
Smoking Tobacco and Drinking Study
NCT03163303
Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial
NCT03380091
The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery
NCT03196505
Daylight Photodynamic Therapy for Actinic Keratosis
NCT03322293
Remotely Resolving Psychological Stress (Remote RePS)
NCT03196999
Postoperative Management of Groin Flaps for Vascular Coverage
NCT03477682
PERsonal ContExtual Precision healTh
NCT03349918
Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device
NCT03252145
Mortality Reduction After Oral Azithromycin Contingency: Mortality Study
NCT03338244
Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth
NCT03765255
Reducing Pesticide Exposures in Child Care Centers
NCT03319927
In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)
NCT02986698
Topical Antibiotic Prophylaxis for Eyelids
NCT03199911
Coaching and Activity Tracking in Multiple Sclerosis - A Pilot Study
NCT03335618
Intraoperative Pleth Variability Index (PVI) Variability
NCT03215238
Recovery After Dialysis-Requiring Acute Kidney Injury
NCT03305549
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
NCT03539562
Acupressure for Children in Treatment for a Childhood Cancer
NCT03313193
Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
NCT03087448
Rehabilitation for Patients With COPD
NCT03287440
Multimodal Sleep Pathway for Shoulder Arthroplasty
NCT03269760
Web-based Professional Development for SMHPs in Evidence-Based Practices for Attention and Behavior Challenges
NCT05713331
Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans
NCT03174444
Duo Partnership Adherence Commitment Therapy
NCT02925949
Evaluation of an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care
NCT02925962
Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
NCT04050371
Clinical Utility of Pediatric Whole Exome Sequencing
NCT03525431
Clinical Utility of Prenatal Whole Exome Sequencing
NCT03482141
Head Pulse for Ischemic Stroke Detection
NCT03824496
Deceased Organ Donor Interventions to Protect Kidney Graft Function
NCT02525510
Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso
NCT03187834
Acute Risk Monitoring for Oncology Therapy Regimen
NCT07601802
Family Input for Quality and Safety
NCT03202888
Sperm Selection by Microfluidic Separation Improves Embryo Quality
NCT03085433
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
NCT03136055
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
NCT03139331
Activity Trackers for Improving BP
NCT03325426
Mindful Mental Training for Surgeons to Enhance Resilience and Performance Under Stress
NCT03141190
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
NCT03590769
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
NCT03609840
Biology and Experience of Eating in Women With Obesity
NCT02805972
Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia)
NCT03160027
BEhavioral EConomics for Oral Health iNnovation Pilot Trial
NCT03862443
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.